Question · asked by 1 review

RISPERIDONE vs CLOZAPINE ‐ all data short term: Adherence to antipsychotic medication: discontinued medication

It is very uncertain whether RISPERIDONE changes adherence to antipsychotic medication: discontinued medication compared with CLOZAPINE ‐ all data short term (very low certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
RISPERIDONE vs CLOZAPINE ‐ all data short term
Adherence to antipsychotic medication: discontinued medication · for people with serious mental illness and co‐occurring substance misuse
It is very uncertain whether RISPERIDONE changes adherence to antipsychotic medication: discontinued medication compared with CLOZAPINE ‐ all data short term (very low certainty).
Risperidone versus other antipsychotics for people with severe mental illness and co‐occurring substance… (2018) · Cochrane Headline outcomes only
RR 4.05 [0.21, 78.76]1 study · 36 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Risperidone versus other antipsychotics for people with severe mental illness and co‐occurring substance misuse
2018 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.